NEW YORK, June 25 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE AMEX: MGT) and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, which assists radiologists in the early detection of disease, is pleased to announce it has signed a non-exclusive, software license and distribution agreement with Alma IT Systems ("Alma"). Alma is a leading developer of advanced digital medical imaging tools, across Europe and South America. This agreement will give Medicsight access to Alma's large and established installed base of radiology customers in key markets.
As part of this agreement Medicsight's ColonCAD API 4.0 software will be integrated into Alma's latest Colon viewer, a 3D visualization workstation which interprets computed tomographic colonography (CTC) image data. Alma is one of Spain's market leaders in medical imaging technology. It is anticipated that the new product will be offered to both clinicians and PACS customers via the ALMA 3D workstation and server-based client platforms.
Commenting on the partnership, Jacobo Gil de Biedma, co-founder and CEO of Alma IT Systems, said, "Alma is a market leader in medical imaging software in Spain and we are quickly gaining market share in Europe and South America. We are seeing a growing demand for CT colonography imaging tools. By developing the latest Alma Colon viewer with the integration of Medicsight's latest ColonCAD application, we can offer our clients complete, fast and reliable imaging technology and continue to consolidate the ALMA 3D platform as a one-stop solution."
Allan Rowley, Chief Executive of Medicsight, commented, "This agreement provides Medicsight with an ideal commercial opportunity to work with Alma and further extend our reach into the European and South American medical imaging markets. We look forward to the swift roll out of the integrated technology."
The prototype Alma 3D Colon viewer is available for demonstration on the Medicsight booth (number 13) at the 20th Annual European Society of Gastrointestinal and Abdominal Radiology (ESGAR 2009) taking place this week in Valencia.
About MGT Capital Investments, Inc.
MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange Ltd.
Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualization workstations of several industry-leading imaging equipment partners.
Medicexchange Ltd. provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.
Additional information can be found at www.mgtci.com.
All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
|SOURCE MGT Capital Investments, Inc.|
Copyright©2009 PR Newswire.
All rights reserved